All Type of News
Government to ameliorate DMF system
The Korea Food and Drug Administration plans to overhaul the drug master file (DMF) system for active pharmaceutical ingredients.
Under the plan, the drug agency will readjust the schedules of DMF related inspectio...
Government urged to delay unified distribution plan
The Korean government needs to consider deferring the controversial unified distribution system which is due to expire at the end of this year, according to Hwawoo, a local law and patent office.
In a statement del...
285 antihypertensive drugs to be excluded from insurance
The Health Insurance Review Assessment and Service announced on September 13 that health insurance will no longer cover a total of 285 antihypertensive agents which have been on market since 2006.
The agency said t...
Individual investor buys 6.4% stake in Samil Pham
An individual investor, known as Choi, bought 350,000 shares of Samil Pharm this month, increasing his stake to 6.4 percent of the total on September 14.
Samil shares closed at 5,500 won on the day, meaning Choi’s ...
Government, multinationals spar over insurance prices of new drugs
The Korean government and some foreign drug manufacturers, including Pfizer Korea and MSD Korea and Abbott Korea, BMS Korea and GlaxoSmithKline, are walking a tightrope not to irritate each other, but their conflictin...
Government to overhaul drug reclassification system
The Ministry of Health and Welfare plans to ameliorate the current drug reclassification system of prescription drugs and over the counter (OTC) drugs as part of its efforts to push for a regulation change.
The min...
Green Cross pushing to acquire foreign vaccine maker
Green Cross plans to take over a foreign pharmaceutical firm producing vaccines within this year, Meritz Securities reported on September 13.
“We are waiting for a good chance to increase its annual sales by 100 bi...
285 high-priced antihypertensive drugs to be delisted from health insurance
The Health Insurance Review Assessment and Service said on September 15 it will exclude a total of 285 antihypertensive agents from health insurance coverage within this year, since they are deemed to less cost-effect...
Bayer Korea punished for exaggerated ads
The Korea Food and Drug Administration has recently reproved Bayer Korea for advertising its vitamin product Redoxon chewable tablet from December last year to April this year, although the company was ordered not to ...
Government set to implement drug pricing reform in October
The government has a plan to gradually lower drug prices in Korea. The plan to be implemented in October, draws a keen attention as Korea faces an urgent need to lower spending on drugs and curb the rising cost of hea...
